Challenges in Clinical Trial Execution for Live Biotherapeutics
Time: 2:00 pm
day: Day 2 Track A AM
Details:
- Introducing B244, a topical live biotherapeutic for the treatment of inflammatory skin disease
- Outlining challenges associated with first-in-class drugs, especially live biotherapeutics
- Improving trial design increased yield efficacy and illuminates a path towards additional indications for B244
